Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis

被引:60
|
作者
Pearce, Fiona A. [1 ,2 ]
Craven, Anthea [3 ]
Merkel, Peter A. [4 ,5 ]
Luqmani, Raashid A. [3 ]
Watts, Richard A. [6 ,7 ]
机构
[1] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham, England
[2] Nottingham Univ Hosp NHS Trust, Dept Rheumatol, Nottingham, England
[3] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[4] Univ Penn, Div Rheumatol, Philadelphia, PA 19104 USA
[5] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[6] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England
[7] Ipswich Hosp NHS Trust, Dept Rheumatol, Ipswich, Suffolk, England
关键词
ANCA-vasculitis; epidemiology; PR3-ANCA; MPO-ANCA; ANCA-ASSOCIATED VASCULITIS; SYSTEMIC VASCULITIS; CLASSIFICATION; GRANULOMATOSIS; EPIDEMIOLOGY; POLYANGIITIS; ALLELES;
D O I
10.1093/rheumatology/kex293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. There are few data on clinical profiles of ANCA-associated vasculitis (AAV) in different ethnic populations. The aim of this study was to examine the differences in the ANCA type and clinical features of AAV between populations using the Diagnostic and Classification Criteria in Vasculitis Study (DCVAS) dataset. Methods. The DCVAS is an international, multicentre, observational study recruiting in 133 sites. Eight ethnic categories were analysed: Northern European, Caucasian American, Southern European, Middle Eastern/Turkish, Chinese, Japanese, Indian subcontinent and other. ANCA type was categorized as myeloperoxidase (MPO), PR3 and ANCA negative. Organ system involvement was recorded using a standard dataset. Differences were analysed by chi-squared tests using a Bonferroni correction and logistic regression (adjusting for age and sex). Northern European was the reference population. Results. Data from 1217 patients with AAV were available and the 967 (79.5%) patients recruited by rheumatology departments were analysed to reduce confounding by recruitment specialty. There were differences in ANCA type between ethnic categories (P < 0.001): MPO-ANCA was more common than PR3-ANCA in Japanese, Chinese and Southern Europeans; PR3-ANCA was more common in the other groups. Compared with Northern Europeans, Japanese had a nearly 60-fold increased chance of having MPO-ANCA (vs PR3-ANCA) [odds ratio (OR) 59.2 (95% CI 8.0, 440.7), P < 0.001] and Chinese had a nearly 7-times increased chance [OR 6.8 (95% CI 2.6, 17.8), P < 0.001]. Ophthalmologic and otorhinolaryngologic involvement were less common in Japanese and Chinese populations than Northern Europeans; otherwise, there were few differences in organ involvement between ethnic groups. Conclusion. This study confirms the previously observed differential occurrence of MPO-AAV and PR3-AAV between different ethnic groups.
引用
收藏
页码:1962 / 1969
页数:8
相关论文
共 50 条
  • [1] Cardiovascular Disease in Anti-neutrophil Cytoplasm Antibody-Associated Vasculitis
    Sayer, Matthew
    Chapman, Gavin B.
    Thomas, Matthew
    Dhaun, Neeraj
    CURRENT RHEUMATOLOGY REPORTS, 2024, 26 (01) : 12 - 23
  • [2] Autoantibodies in anti-neutrophil cytoplasm antibody-associated vasculitis
    Salama, Alan D.
    Rees, Andrew J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (06) : 1105 - 1107
  • [3] Anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical aspects and treatment
    Virginia Paolini, Maria
    Pablo Ruffino, Juan
    Fernandez Romero, Diego S.
    MEDICINA-BUENOS AIRES, 2013, 73 (02) : 119 - 126
  • [4] Rituximab in the Treatment of Anti-Neutrophil Cytoplasm Antibody-Associated Vasculitis
    Jones, Rachel B.
    NEPHRON CLINICAL PRACTICE, 2014, 128 (3-4): : 243 - 249
  • [5] Cardiovascular Disease in Anti-neutrophil Cytoplasm Antibody-Associated Vasculitis
    Matthew Sayer
    Gavin B. Chapman
    Matthew Thomas
    Neeraj Dhaun
    Current Rheumatology Reports, 2024, 26 : 12 - 23
  • [6] Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis
    Guerry, Mary-Jane C. J.
    Brogan, Paul
    Bruce, Ian N.
    D'Cruz, David P.
    Harper, Lorraine
    Luqmani, Raashid
    Pusey, Charles D.
    Salama, Alan D.
    Scott, David G. I.
    Savage, Caroline O. S.
    Watts, Richard A.
    Jayne, David R. W.
    RHEUMATOLOGY, 2012, 51 (04) : 634 - 643
  • [7] Plasma exchange as an adjunctive therapy in anti-neutrophil cytoplasm antibody-associated vasculitis
    Gulati, Kavita
    Pusey, Charles D.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (04) : 417 - 430
  • [8] Clinical associations with venous thromboembolism in anti-neutrophil cytoplasm antibody-associated vasculitides
    Kronbichler, Andreas
    Leierer, Johannes
    Leierer, Gisela
    Mayer, Gert
    Casian, Alina
    Hoglund, Peter
    Westman, Kerstin
    Jayne, David
    RHEUMATOLOGY, 2017, 56 (05) : 704 - 708
  • [9] Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
    Suzuki, Junya
    Furuta, Shunsuke
    Sugiyama, Takahiro
    Iwamoto, Taro
    Ikeda, Kei
    Suzuki, Kotaro
    Nakajima, Hiroshi
    MODERN RHEUMATOLOGY, 2023, 33 (02) : 346 - 351
  • [10] A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis
    Pepper, Ruth J.
    McAdoo, Stephen P.
    Moran, Sarah M.
    Kelly, Dearbhla
    Scott, Jennifer
    Hamour, Sally
    Burns, Aine
    Griffith, Megan
    Galliford, Jack
    Levy, Jeremy B.
    Cairns, Thomas D.
    Gopaluni, Seerapani
    Jones, Rachel B.
    Jayne, David
    Little, Mark A.
    Pusey, Charles D.
    Salama, Alan D.
    RHEUMATOLOGY, 2019, 58 (02) : 260 - 268